Both in Biotechnology
Tevogen vs Outlook Therapeutics
Over the past year TVGN returned −79.6% and OTLK returned −62.7%; their daily moves had a correlation of 0.01.
TVGN −79.6% OTLK −62.7%Growth of $1, one year, split-adjusted
| Metric | TVGN | OTLK |
|---|---|---|
| Price | $6.40 | $0.5001 |
| Market cap | $100.7M | $121.7M |
| Today | −1.99% | −3.70% |
| 1 month | −11.7% | −21.8% |
| 6 months | −8.6% | +75.5% |
| Year to date | −61.3% | −68.3% |
| 1 year | — | −61.5% |
| Revenue growth (YoY) | — | −99.4% |
| Gross margin | — | −95.0% |
| Net margin | — | −233554.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$7.0M | -$7.0M |
| Dividend yield | — | — |
| Volatility (60d) | 59.4% | 94.7% |
| Short % of float | 3.9% | 38.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).